Key facts
- It has raised $150K; the latest was Early Stage VC ($150K) in Jan 2026.
- Notable investors include Rev1 Ventures, Ohio Department of Development.
- LAACClamp has filed 1 Form D with the SEC, most recently Jan 2026 ($150K sold to 4 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for LAACClamp
- ·The full record, as it builds
Funding rounds
No funding rounds for LAACClamp are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LAACClamp
Developer of a novel epicardial exclusion system intended to enhance the lives of cardiac surgery patients. The company's technology conforms to the curved anatomy of the LAA, reducing the risk of residual stump and stroke, enabling patients to receive cost-effective, user-friendly surgical devices.
- Sector
- Healthcare
- HQ
- Columbus, OH, United States
- Founded
- 2023
- Website
- laacclamp.com/
- Ownership
- Privately Held (backing)
LAACClamp doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LAACClamp shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LAACClamp in its N-PORT filings yet. We sweep new filings monthly.